What is Compass Therapeutics, Inc. Common Stock's Market Cap?

Compass Therapeutics, Inc. Common Stock's Market Cap is $398.0M, based on as-reported figures from SEC (XBRL) filings.

What is Compass Therapeutics, Inc. Common Stock's Revenue (TTM)?

Compass Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Compass Therapeutics, Inc. Common Stock's Net Income (TTM)?

Compass Therapeutics, Inc. Common Stock's Net Income (TTM) is -$73.4M, based on as-reported figures from SEC (XBRL) filings.

What is Compass Therapeutics, Inc. Common Stock's EBITDA?

Compass Therapeutics, Inc. Common Stock's EBITDA is -$81.0M, based on as-reported figures from SEC (XBRL) filings.

What is Compass Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Compass Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.41, based on as-reported figures from SEC (XBRL) filings.

Compass Therapeutics, Inc. Common Stock (CMPX) Financial Statements

Compass Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00LPXKF34

XNAS · usd

2.21▼ 0.17 (-7.14%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close2.38

Day's Range2.20 – 2.33

52-Week Range1.61 – 6.95

Volume2.4M

Avg Volume3.0M

Share Statistics

Shares Outstanding

Employees39

ExchangeXNAS

Listed2020-11-13

Share count as of July 28, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Compass Therapeutics, Inc. Common Stock (CMPX)

What is Compass Therapeutics, Inc. Common Stock's Market Cap?: Compass Therapeutics, Inc. Common Stock's Market Cap is $398.0M, based on as-reported figures from SEC (XBRL) filings.
What is Compass Therapeutics, Inc. Common Stock's Revenue (TTM)?: Compass Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Compass Therapeutics, Inc. Common Stock's Net Income (TTM)?: Compass Therapeutics, Inc. Common Stock's Net Income (TTM) is -$73.4M, based on as-reported figures from SEC (XBRL) filings.
What is Compass Therapeutics, Inc. Common Stock's EBITDA?: Compass Therapeutics, Inc. Common Stock's EBITDA is -$81.0M, based on as-reported figures from SEC (XBRL) filings.
What is Compass Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Compass Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.41, based on as-reported figures from SEC (XBRL) filings.